LIVE - Physiologyに基づいた冠血行再建 Update 2021
割澤高行先生は、聖マリアンナ医科大学 横浜市西部病院、岐阜ハートセンターの日本のカテーテルインターベンション医です。本シリーズは、割澤先生が冠動脈疾患の各分野のキーオピニオンリーダー(KOL)をお招きし、KOLからの貴重なご講義に続いて、他では言えない本音をKOLにざっくざっくと尋ねていく、Discussion形式のコースです。
Please note this is a Japanese...
割澤高行先生は、聖マリアンナ医科大学 横浜市西部病院、岐阜ハートセンター の日本のカテーテルインターベンション医です。本シリーズは、割澤先生が冠動脈疾患の各分野のキーオピニオンリーダー(KOL)をお招きし、KOLからの貴重なご講義に続いて、他では言えない本音をKOLにざっくざっくと尋ねていく、Discussion形式のコースです。
Please note this is a Japanese language webinar series
Speakers
Prof Hitoshi Matsuo is currently President of Gifu Heart Center, and Clinical Visiting Professor of Cardiology in...
Prof Hitoshi Matsuo is currently President of Gifu Heart Center, and Clinical Visiting Professor of Cardiology in Aichi Medical University. He graduated from Jichi Medical School in 1986 and completed his residency in Gifu Prefectural Gifu Hospital. In 1987, during his residency period, Prof Hitoshi Matsuo spent one year at Johns Hopkins Medical Institutions in Baltimore as a research fellow in the Nuclear Medicine Department under the supervision of Professor Henry N Wagner Jr. From 1988, he returned to Gifu Prefectural Hospital where he dedicated clinical research work on physiology and interventional cardiology using nuclear medicine and pressure wires. He received an annual award of Japanese Society of Nuclear Medicine in 1995 and the Clinical Research Award of Japanese Society of Interventional Cardiology in 2004. Thereafter, he moved to Toyohashi Heart Center as co-director of the catheterization laboratory from 2007 and returned to Gifu as the Director of Cardiovascular Medicine in 2009. Dr Matsuo now participates and contributes to many international multi-center trials including DEFINE-FLAIR, the international multicenter FFRCT registry (ADVANCE registry), 3V-FFR FRIENDS study and FAVOR2 Europe and Japan, DEFINE FLOW study.
Dr Takayuki Warisawa is a Consultant Interventional Cardiologist at NTT Medical Center Tokyo and St. Marianna...
Dr Takayuki Warisawa is a Consultant Interventional Cardiologist at NTT Medical Center Tokyo and St. Marianna University School of Medicine in Japan. After graduating with honours from the prestigious University of Tokyo, he concentrated on clinical work, especially in the field of cardiology, emergency medicine, and intensive care. He trained as an interventional cardiologist for five years at New Tokyo Hospital, which is renowned for high-level interventional cardiology and clinical research. There, he developed skill and insight for complex PCI procedure. He had also taken the role of the Director of Emergency Medicine. While working as an expert clinician, he performed many clinical studies focused on the invasive and non-invasive coronary physiology including NHPRs/FFR, IMR/CFR, Scintigraphy and Perfusion CMR. Many of the studies have been published in international journals and a selection have been awarded at the Japanese and international scientific congresses. After working at Imperial College London in U.K. for 2 years, Dr Warisawa has been working on several clinical studies with international collaborators, as well as working as a chief of coronary intervention division and a chief of cardiovascular intensive care unit at NTT Medical Center Tokyo. For his many contributions and activities, he has received many awards and accolades, and the most recent include: The Young Investigator Award at the 30th Japanese Society of Cardiovascular Intervention and Therapeutics in 2022, PCR's Got Talent Finalist at Euro PCR 2022, The 58th District Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics in Kanto Koshinetsu in 2021, The 25th Beyond Angiography Japan and Young Investigator Award, The Award for the Best Scientific Research, Tokyo Percutaneous Cardiovascular Intervention Conference 2017. He is a leading Japanese doctor who is active both in Japan and abroad.